318 related articles for article (PubMed ID: 19846552)
1. The Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection.
McLean KJ; Lafite P; Levy C; Cheesman MR; Mast N; Pikuleva IA; Leys D; Munro AW
J Biol Chem; 2009 Dec; 284(51):35524-33. PubMed ID: 19846552
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterial cytochrome p450 125 (cyp125) catalyzes the terminal hydroxylation of c27 steroids.
Capyk JK; Kalscheuer R; Stewart GR; Liu J; Kwon H; Zhao R; Okamoto S; Jacobs WR; Eltis LD; Mohn WW
J Biol Chem; 2009 Dec; 284(51):35534-42. PubMed ID: 19846551
[TBL] [Abstract][Full Text] [Related]
3. Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.
Driscoll MD; McLean KJ; Levy C; Mast N; Pikuleva IA; Lafite P; Rigby SE; Leys D; Munro AW
J Biol Chem; 2010 Dec; 285(49):38270-82. PubMed ID: 20889498
[TBL] [Abstract][Full Text] [Related]
4. A comparison of steroid and lipid binding cytochrome P450s from Mycobacterium marinum and Mycobacterium tuberculosis.
Child SA; Ghith A; Bruning JB; Bell SG
J Inorg Biochem; 2020 Aug; 209():111116. PubMed ID: 32473484
[TBL] [Abstract][Full Text] [Related]
5. An enlarged, adaptable active site in CYP164 family P450 enzymes, the sole P450 in Mycobacterium leprae.
Agnew CR; Warrilow AG; Burton NM; Lamb DC; Kelly SL; Brady RL
Antimicrob Agents Chemother; 2012 Jan; 56(1):391-402. PubMed ID: 22037849
[TBL] [Abstract][Full Text] [Related]
6. Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1.
Chenge JT; Duyet LV; Swami S; McLean KJ; Kavanagh ME; Coyne AG; Rigby SE; Cheesman MR; Girvan HM; Levy CW; Rupp B; von Kries JP; Abell C; Leys D; Munro AW
J Biol Chem; 2017 Jan; 292(4):1310-1329. PubMed ID: 27932461
[TBL] [Abstract][Full Text] [Related]
7. Structure-Function Analysis of the Essential
Padayachee T; Lamb DC; Nelson DR; Syed K
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732102
[TBL] [Abstract][Full Text] [Related]
8. Biophysical characterization of the sterol demethylase P450 from Mycobacterium tuberculosis, its cognate ferredoxin, and their interactions.
McLean KJ; Warman AJ; Seward HE; Marshall KR; Girvan HM; Cheesman MR; Waterman MR; Munro AW
Biochemistry; 2006 Jul; 45(27):8427-43. PubMed ID: 16819841
[TBL] [Abstract][Full Text] [Related]
9. Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv.
McLean KJ; Carroll P; Lewis DG; Dunford AJ; Seward HE; Neeli R; Cheesman MR; Marsollier L; Douglas P; Smith WE; Rosenkrands I; Cole ST; Leys D; Parish T; Munro AW
J Biol Chem; 2008 Nov; 283(48):33406-16. PubMed ID: 18818197
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the Mycobacterium tuberculosis P450 CYP121-fluconazole complex reveals new azole drug-P450 binding mode.
Seward HE; Roujeinikova A; McLean KJ; Munro AW; Leys D
J Biol Chem; 2006 Dec; 281(51):39437-43. PubMed ID: 17028183
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol ester oxidation by mycobacterial cytochrome P450.
Frank DJ; Madrona Y; Ortiz de Montellano PR
J Biol Chem; 2014 Oct; 289(44):30417-30425. PubMed ID: 25210044
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis CYP130: crystal structure, biophysical characterization, and interactions with antifungal azole drugs.
Ouellet H; Podust LM; de Montellano PR
J Biol Chem; 2008 Feb; 283(8):5069-80. PubMed ID: 18089574
[TBL] [Abstract][Full Text] [Related]
13. Probing Ligand Exchange in the P450 Enzyme CYP121 from Mycobacterium tuberculosis: Dynamic Equilibrium of the Distal Heme Ligand as a Function of pH and Temperature.
Fielding AJ; Dornevil K; Ma L; Davis I; Liu A
J Am Chem Soc; 2017 Dec; 139(48):17484-17499. PubMed ID: 29090577
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of bacterial CYP116B5 heme domain: New insights on class VII P450s structural flexibility and peroxygenase activity.
Ciaramella A; Catucci G; Gilardi G; Di Nardo G
Int J Biol Macromol; 2019 Nov; 140():577-587. PubMed ID: 31430491
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 125 (CYP125) catalyses C26-hydroxylation to initiate sterol side-chain degradation in Rhodococcus jostii RHA1.
Rosłoniec KZ; Wilbrink MH; Capyk JK; Mohn WW; Ostendorf M; van der Geize R; Dijkhuizen L; Eltis LD
Mol Microbiol; 2009 Dec; 74(5):1031-43. PubMed ID: 19843222
[TBL] [Abstract][Full Text] [Related]
16. Atomic structure of Mycobacterium tuberculosis CYP121 to 1.06 A reveals novel features of cytochrome P450.
Leys D; Mowat CG; McLean KJ; Richmond A; Chapman SK; Walkinshaw MD; Munro AW
J Biol Chem; 2003 Feb; 278(7):5141-7. PubMed ID: 12435731
[TBL] [Abstract][Full Text] [Related]
17. Structural diversities of active site in clinical azole-bound forms between sterol 14alpha-demethylases (CYP51s) from human and Mycobacterium tuberculosis.
Matsuura K; Yoshioka S; Tosha T; Hori H; Ishimori K; Kitagawa T; Morishima I; Kagawa N; Waterman MR
J Biol Chem; 2005 Mar; 280(10):9088-96. PubMed ID: 15611056
[TBL] [Abstract][Full Text] [Related]
18. Deletion of cyp125 Confers Increased Sensitivity to Azoles in Mycobacterium tuberculosis.
Carroll P; Parish T
PLoS One; 2015; 10(7):e0133129. PubMed ID: 26197389
[TBL] [Abstract][Full Text] [Related]
19. Expression and characterization of Mycobacterium tuberculosis CYP144: common themes and lessons learned in the M. tuberculosis P450 enzyme family.
Driscoll MD; McLean KJ; Cheesman MR; Jowitt TA; Howard M; Carroll P; Parish T; Munro AW
Biochim Biophys Acta; 2011 Jan; 1814(1):76-87. PubMed ID: 20621636
[TBL] [Abstract][Full Text] [Related]
20. Structural basis of steroid binding and oxidation by the cytochrome P450 CYP109E1 from Bacillus megaterium.
Jóźwik IK; Kiss FM; Gricman Ł; Abdulmughni A; Brill E; Zapp J; Pleiss J; Bernhardt R; Thunnissen AW
FEBS J; 2016 Nov; 283(22):4128-4148. PubMed ID: 27686671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
